Over the last few years, our ability to make sense of biological information has increased in sophistication. Today, we can predict the 3-dimensional structure of an enzyme, simulate activity and optimize the molecule using computational biotechnology tools. The cost of biological information/data has also dramatically declined. In the podcast we speak with Jens Kolind from Novozymes on what all this means for water going forward and the challenges in implementing biotechnology on a wider scale in water treatment. We also focus in on industrial Stormwater and speak to Ryan Janoch from Mapistry. The interest in this area is fast growing at both a public and company level. For a company, industrial stormwater presents both an environmental and financial risk. The Clean Water Federation Act offers an opportunity for citizens to file a complaint against non-compliant companies on behalf of public and regulatory agencies. The rate of lawsuits filed against organizations in California has increased to 30 a month and it is likely this will occur in other parts of the United States. This litigation aspect will likely tighten stormwater permits across the country in the coming years.

--
Presented by BlueTech Research®, Actionable Water Technology Market Intelligence.

Watch the trailer of Our Blue World: A Water Odyssey. Get involved, and learn more on the website: braveblue.world